ASX 200 healthcare shares provided some pain relief today. Here's why

The healthcare sector ended Thursday as the best performer on the ASX.

A man in a wheelchair stretches both arms into the air in success.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • The ASX 200 Health Care index closed slightly lower on Thursday but still outperformed the broader market
  • The smaller cap healthcare shares helped make it the best-performing sector on the ASX
  • Global healthcare index leader CSL closed just 0.27% lower having been in positive territory for much of the day

A number of ASX shares in the S&P/ASX 200 Health Care Index (ASX: XHJ) outperformed the broader market today.

The benchmark S&P/ASX 200 Index (ASX: XJO) backtracked yet again, ending Thursday's session 1.97% lower at 6,568.1 points.

In contrast, the healthcare sector was the best performer on the ASX today, falling just 0.19% after spending much of the day in the green.

What's happening in the ASX 200 healthcare sector?

The biggest and most heavily weighted share price within the ASX 200 healthcare sector is CSL Limited (ASX: CSL).

The global biotech outperformed the ASX 200, closing just 0.27% lower at $269.06. Much like the healthcare index, it was in positive territory for most of the day before retreating late in the session.

However, it was the smaller cap companies such as Paradigm Biopharmaceuticals Ltd (ASX: PAR) and Recce Pharmaceuticals Ltd (ASX: RCE) that led the charge. They gained 10.29% and 9.88%, respectively.

Paradigm reported a positive release before market open, stating it had received official acceptance of an Australian patent application. However, there was no fresh news out of Recce Pharmaceuticals.

Meanwhile, the Race Oncology Ltd (ASX: RAC) share price gained 4.84% after the company released the latest interim results from its preclinical cardioprotection program.

While the ASX 200 Health Care index has rebounded 3.2% this week, it's still down 12% year-to-date.

The ASX has been hit hard in recent weeks following high inflation levels and aggressive rate hikes.

During the March quarter, inflation rose by 5.1%, the highest increase in many years. This led the Reserve Bank of Australia to ramp up the official cash rate by 0.5% to 0.85%.

Foolish takeaway

Investing in an ASX-index tracking fund is considered a much safer alternative than picking an individual company.

This is because the sector is relatively impervious to wild swings from any one share price.

Furthermore, it's worth noting that an index has historically provided long-term stable growth.

It is often the most boring investments that reap the largest rewards.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Index investing

Man smiling at a laptop because of a rising share price.
Index investing

If you invested $5,000 in the Vanguard Australian Shares ETF (VAS) 5 years ago, here's how much you'd have today

This popular index fund's returns may surprise you.

Read more »

An evening shot of a busy Times Square in New York.
Index investing

Is the ASX-listed S&P 500 ETF (IVV) a simple way to buy the dip in US stocks?

It's not hard to buy S&P 500 shares on the ASX.

Read more »

A couple sitting in their living room and checking their finances.
Index investing

Why I prefer the ASX 200 over the S&P 500 right now

There are two reasons why I'm going for ASX shares over American stocks right now.

Read more »

Unsure man analysing data on laptop.
Index investing

Expert: S&P 500 shares could be in for a 'lost decade'

This expert is predicting that American shares' stunning past performance won't continue.

Read more »

Woman with $50 notes in her hand thinking, symbolising dividends.
Index investing

Here is the current dividend yield of the Vanguard Australian Shares Index ETF (VAS)

This ETF's dividends can vary wildly from year to year.

Read more »

Man smiling at a laptop because of a rising share price.
Index investing

Should you buy the Vanguard MSCI Index International Shares ETF (VGS) at all-time ASX highs?

Is it too late to buy this index fund?

Read more »

A young couple hug each other and smile at the camera standing in front of their brand new luxury car
Index investing

These 2 simple ASX index funds could turn $100 a month into $1 million

Index funds can help anyone build wealth on the stock market...

Read more »

An evening shot of a busy Times Square in New York.
Index investing

3 reasons to buy the iShares S&P 500 ETF (and 2 not to)

This index fund has many advantages, but also a few faults.

Read more »